Denali Therapeutics Inc. Income Taxes Paid
Denali Therapeutics Inc. (DNLI) reported Income Taxes Paid of $46.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-26
- Denali Therapeutics Inc. income taxes paid, net for the quarter ending 2024-12-31 was $0.00.
- Denali Therapeutics Inc. income taxes paid, net for the quarter ending 2024-09-30 was $0.00.
- Denali Therapeutics Inc. income taxes paid, net for the quarter ending 2024-06-30 was $0.00.
- Denali Therapeutics Inc. income taxes paid, net for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Denali Therapeutics Inc. income taxes paid, net for fiscal 2025 was $46.00K.
- Denali Therapeutics Inc. income taxes paid, net for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Denali Therapeutics Inc. income taxes paid, net for fiscal 2023 was $3.00K, a 93.62% decline from fiscal 2022.
- Denali Therapeutics Inc. income taxes paid, net for fiscal 2022 was $47.00K, a 77.62% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $46.00K 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | -$1.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | -$1.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | -$1.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.00K derived: sum of 3 quarters · filed 2026-02-26 | $3.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $4.00K 10-Q · filed 2024-11-06 | $51.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $4.00K 10-Q · filed 2024-08-01 | $51.00K derived: sum of 3 quarters · filed 2025-02-27 | $51.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-07 | $51.00K derived: sum of 2 quarters · filed 2025-02-27 | $51.00K derived: sum of 3 quarters · filed 2025-02-27 | $51.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $47.00K derived: sum of 2 quarters · filed 2025-02-27 | $47.00K derived: sum of 3 quarters · filed 2025-02-27 | $47.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $210.00K 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |